Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2026-02-03 @ 3:39 AM
Study NCT ID:
NCT05473195
Status:
COMPLETED
Last Update Posted:
2025-08-21
First Post:
2022-07-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098
Sponsor:
TASK Applied Science
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) | View |
Keywords: